ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,928Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 54

$620K Total Retail Price of All Prescriptions

Rank: 8 out of 54

409 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

4% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,683 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 710 641 1 1
LEVOTHYROXINE SODIUM 470 377 2 2
SIMVASTATIN 391 331 3 5
METOPROLOL TARTRATE 342 329 4 7
FUROSEMIDE 326 302 5 3
LISINOPRIL 291 267 6 6
AMLODIPINE BESYLATE 264 234 7 4
ATORVASTATIN CALCIUM 243 206 8 15
HYDROCHLOROTHIAZIDE 194 176 9 20
DONEPEZIL HCL 185 185 10 8
OMEPRAZOLE 179 136 11 9
NAMENDA 152 152 12 13
SERTRALINE HCL 144 140 13 12
GABAPENTIN 136 125 14 16
MIRTAZAPINE 135 135 15 11
METOPROLOL SUCCINATE 122 103 16 14
RISPERIDONE 114 114 17 23
POTASSIUM CHLORIDE 111 103 18 22
ESCITALOPRAM OXALATE 108 108 19 18
METFORMIN HCL 103 90 20 19
ALENDRONATE SODIUM 102 70 21 31
DIOVAN 99 86 22 29
ATENOLOL 79 75 23 24
CYMBALTA 76 65 24 26
TAMSULOSIN HCL 76 73 24 25
DIVALPROEX SODIUM 76 76 24 28
ZOLPIDEM TARTRATE 75 69 27 35
PRAVASTATIN SODIUM 74 70 28 27
AZITHROMYCIN 71 58 29 65
ZETIA 69 51 30 120
OXYBUTYNIN CHLORIDE ER 69 63 30 62
CLOPIDOGREL 67 67 32 38
TRAZODONE HCL 66 66 33 10
LEVETIRACETAM 64 52 34 46
LIDODERM 63 58 35 44
QUETIAPINE FUMARATE 60 60 36 21
ADVAIR DISKUS 59 55 37 42
SPIRIVA 57 56 38 51
TRAMADOL HCL 55 53 39 32
QUINAPRIL HCL 54 52 40 126
CLONIDINE HCL 53 50 41 173
LOVASTATIN 53 53 41 53
PLAVIX 52 52 43 59
BACLOFEN 52 0 43 75
LANTUS 52 43 43 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.